Advanced Gastroenterology Associates, LLC
Palm Harbor, Florida 34684
We've found
8 trials
at this facility
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 11/11/2013
Study of the Safety and Efficacy of Zoenasa® Versus Mesalamine Enema in Subjects With Left-Sided Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 11/11/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Idiopathic Constipation Clinical Trial
Updated: 4/25/2014
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation
Status: Enrolling,
Phase
II
Updated: 4/25/2014
Click here to add this to my saved trials
Gastroesophageal Reflux Disease (GERD) Clinical Trial
Updated: 12/31/1969
A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials